Tianxin Xu

446 total citations
23 papers, 293 citations indexed

About

Tianxin Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Tianxin Xu has authored 23 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Tianxin Xu's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (3 papers). Tianxin Xu is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (3 papers). Tianxin Xu collaborates with scholars based in China, Germany and United States. Tianxin Xu's co-authors include Wenbo Nie, Lisheng Wang, Lin Du, Lijing Zhao, Yuxiang Li, Fengjun Xiao, Prem Seth, Hua Wang, Aimei Zhang and Dan Zhang and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Experimental Cell Research.

In The Last Decade

Tianxin Xu

18 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianxin Xu China 9 84 77 61 42 40 23 293
Azadeh Omidkhoda Iran 11 103 1.2× 61 0.8× 20 0.3× 22 0.5× 33 0.8× 28 284
R. Metzger Germany 12 35 0.4× 140 1.8× 73 1.2× 22 0.5× 33 0.8× 26 364
Linye He China 10 98 1.2× 75 1.0× 40 0.7× 7 0.2× 12 0.3× 16 435
Silvia Ferrari Italy 10 48 0.6× 55 0.7× 39 0.6× 13 0.3× 8 0.2× 18 269
Ryoko Hamaguchi United States 10 52 0.6× 166 2.2× 131 2.1× 33 0.8× 13 0.3× 30 377
Kevin Watters Canada 9 30 0.4× 50 0.6× 42 0.7× 8 0.2× 15 0.4× 27 279
Angela A. Chang United States 9 56 0.7× 105 1.4× 73 1.2× 15 0.4× 19 0.5× 14 308
Kathryn C. Behling United States 12 29 0.3× 127 1.6× 23 0.4× 13 0.3× 33 0.8× 39 477
Fernando Callera Brazil 10 37 0.4× 58 0.8× 44 0.7× 25 0.6× 8 0.2× 21 302
Kiet T. Phong United States 10 67 0.8× 91 1.2× 61 1.0× 53 1.3× 11 0.3× 14 357

Countries citing papers authored by Tianxin Xu

Since Specialization
Citations

This map shows the geographic impact of Tianxin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianxin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianxin Xu more than expected).

Fields of papers citing papers by Tianxin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianxin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianxin Xu. The network helps show where Tianxin Xu may publish in the future.

Co-authorship network of co-authors of Tianxin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Tianxin Xu. A scholar is included among the top collaborators of Tianxin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianxin Xu. Tianxin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Jie, Wenchao Gu, Tianxin Xu, et al.. (2025). 5’-transfer RNA halve-lysine-CTT as a promising biomarker for early detection of hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 17(11). 111142–111142.
2.
Tang, Peng, Zhenwei Han, Tianxin Xu, et al.. (2025). ALG3 as a prognostic biomarker and mediator of PD-1 blockade resistance in hepatocellular carcinoma. Frontiers in Immunology. 16. 1589153–1589153. 1 indexed citations
3.
Xu, Tianxin, Daokun Ma, Wei Fang, & Yujie Huang. (2025). Experimental Study on the Propagation Characteristics of LoRa Signals in Maize Fields. Electronics. 14(11). 2156–2156.
4.
Xu, Tianxin, et al.. (2024). Deep learning tool: reconstruction of long missing climate data based on spatio-temporal multilayer perceptron. Theoretical and Applied Climatology. 155(7). 5835–5847.
5.
Xu, Tianxin, et al.. (2024). Deep learning models for groundwater level prediction based on delay penalty. Water Science & Technology Water Supply. 24(2). 555–567. 8 indexed citations
6.
Xu, Tianxin, et al.. (2024). Exploring the functional role of tRF-39-8HM2OSRNLNKSEKH9 in hepatocellular carcinoma. Heliyon. 10(5). e27153–e27153. 3 indexed citations
7.
Yuan, Jie, et al.. (2024). Dysregulated transfer RNA-derived small RNAs as potential gastric cancer biomarkers. Experimental Biology and Medicine. 249. 10170–10170. 1 indexed citations
9.
Xu, Yang, Tianxin Xu, Yan Huang, Jian Wan, & Zhaoyan Jiang. (2023). Silencing hsa_circ_0032449 inhibits the pancreatic differentiation of human embryonic stem cells via the hsa_miR-195-5p/CCND1/PI3K/AKT signaling pathway. Experimental Cell Research. 434(2). 113879–113879. 1 indexed citations
11.
Nie, Wenbo, Lijing Zhao, Taiwei Wang, et al.. (2023). Exosomal miR-17–92 derived from human mesenchymal stem cells promotes wound healing by enhancing angiogenesis and inhibiting endothelial cell ferroptosis. Tissue and Cell. 83. 102124–102124. 29 indexed citations
12.
Gao, Cheng, et al.. (2023). AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 14(3). 1412–1433. 6 indexed citations
13.
Xu, Tianxin, et al.. (2023). Machine learning in predicting outcomes for stroke patients following rehabilitation treatment: A systematic review. PLoS ONE. 18(6). e0287308–e0287308. 10 indexed citations
14.
Gao, Cheng, et al.. (2023). RBM12 regulates the progression of hepatocellular cancer via miR-497–5p/CPNE1 Axis. Environmental Research. 239(Pt 1). 117203–117203.
15.
Wang, Taiwei, Tianxin Xu, Lin Du, et al.. (2022). A bibliometric analysis of global publications on graft-versus-host disease research. Medicine. 101(27). e29634–e29634. 3 indexed citations
16.
Du, Lin, et al.. (2022). Blended learning vs traditional teaching: The potential of a novel teaching strategy in nursing education - a systematic review and meta-analysis. Nurse Education in Practice. 63. 103354–103354. 63 indexed citations
17.
Li, Yuxiang, Lin Zhang, Tianxin Xu, et al.. (2021). Aberrant ENPP2 expression promotes tumor progression in multiple myeloma. Leukemia & lymphoma. 63(4). 963–974. 2 indexed citations
18.
Li, Yuxiang, Fengjun Xiao, Aimei Zhang, et al.. (2020). Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer. Cellular Immunology. 348. 104041–104041. 69 indexed citations
19.
Wu, Di, Jian Wan, Yan Huang, et al.. (2015). 3D Culture of MIN-6 Cells on Decellularized Pancreatic Scaffold: In Vitro and In Vivo Study. BioMed Research International. 2015. 1–8. 40 indexed citations
20.
Hu, Baoying, Runzhou Ni, Dawei Jiang, et al.. (2014). The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Molecular and Cellular Biochemistry. 396(1-2). 175–185. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026